AIM arrivals and departures - November 2015
It was yet another quiet month for new issuance on AIM with only two legitimate new arrivals (from very different sectors), two transfers from the main market and a single relisting. As usual, our updated AIMsearch search tool can offer guidance on which AIM companies, including the new arrivals, benefit from the valuable tax benefits.
At the end of November 2015 there were 1,049 companies on AIM with a market value of £73.9bn. This compares with 1,056 companies on AIM at the end of October 2015 when the market value was £73.6bn. The new arrivals came from sectors that have been polar opposites in terms of investor appeal over the past 12 months; Biotechnology and Exploration & Production. Faron Pharmaceuticals Oy (AIM:FARN) is a clinical stage drug discovery and development company based in Turku, Finland. Faron has a pipeline of clinical stage products focusing on acute organ traumas, cancer immunotherapy and vascular damage. The Group…